Decision of the European Medicines Agency on rules relating to Articles 11, 11a and 13 of the Staff Regulations concerning the handling of declared interests of staff members of the European Medicines Agency and candidates before recruitment

Submitted by Anonymous (not verified) on 26 March 2025 - 8:04

Decision of the European Medicines Agency on rules relating to Articles 11, 11a and 13 of the Staff Regulations concerning the handling of declared interests of staff members of the European Medicines Agency and candidates before recruitment

Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 28, Status: Authorised

Submitted by Anonymous (not verified) on 25 March 2025 - 16:45

Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177 Lu) chloride, Date of authorisation: 06/07/2016, Revision: 10, Status: Authorised

Submitted by Anonymous (not verified) on 25 March 2025 - 16:05

Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177 Lu) chloride, Date of authorisation: 06/07/2016, Revision: 10, Status: Authorised

Second EMA / Alliance for Regenerative Medicine bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 May 2025, 14:00 (CEST) to 8 May 2025, 16:00 (CEST)

Submitted by Anonymous (not verified) on 25 March 2025 - 15:25

Second EMA / Alliance for Regenerative Medicine bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 May 2025, 14:00 (CEST) to 8 May 2025, 16:00 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More